Roche first-quarter sales declined on weak demand for its Covid-19 products and currency headwinds but it remained confident of meeting its full-year guidance.
Roche first-quarter sales declined on weak demand for its Covid-19 products and currency headwinds but it remained confident of meeting its full-year guidance.